跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 302 条关于
“OctoPlus NV”
全部
302
临床试验
56
药物
93
机构
46
资讯
107
去年
Dr Reddy's Laboratories to Acquire Dutch Injectable Specialist OctoPlus for €27.39M
2年前
NanoViricides' NV-387 Shows Broad-Spectrum Antiviral Activity Against 'Tripledemic' Viruses and Smallpox in Animal Models
2年前
NanoViricides Develops First-In-Class Broad-Spectrum Antiviral Agent NV-387
去年
NanoViricides' NV-387 Advances to Phase II Clinical Trials for MPox Treatment
去年
NanoViricides Advances NV-387 to Phase II Trials Targeting MPox and Respiratory Infections
去年
NanoViricides Advances NV-387 for Herpes Zoster Treatment to Phase II Trials
去年
NanoViricides' NV-387 Advances to Phase II Trials for Multiple Viral Infections
去年
NanoViricides Advances NV-387 as Potential Treatment for Measles Amid Declining Vaccination Rates
去年
NanoViricides' NV-387 Shows Promise Against H5N1 Bird Flu in Preclinical Studies
去年
NanoViricides' NV-387 Shows Promise Against Multiple Viral Threats Following Successful Phase I Trial
第 1 页,共 11 页
上一页
下一页